Cargando…
Utilizing Nanobody Technology to Target Non-Immunodominant Domains of VAR2CSA
Placental malaria is a major health problem for both pregnant women and their fetuses in malaria endemic regions. It is triggered by the accumulation of Plasmodium falciparum-infected erythrocytes (IE) in the intervillous spaces of the placenta and is associated with foetal growth restriction and ma...
Autores principales: | Ditlev, Sisse B., Florea, Raluca, Nielsen, Morten A., Theander, Thor G., Magez, Stefan, Boeuf, Philippe, Salanti, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897377/ https://www.ncbi.nlm.nih.gov/pubmed/24465459 http://dx.doi.org/10.1371/journal.pone.0084981 |
Ejemplares similares
-
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
por: Salanti, Ali, et al.
Publicado: (2010) -
Identification and Characterization of B-Cell Epitopes in the DBL4ε Domain of VAR2CSA
por: Ditlev, Sisse B., et al.
Publicado: (2012) -
The Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains
por: Dahlbäck, Madeleine, et al.
Publicado: (2011) -
Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA
por: Resende, Mafalda, et al.
Publicado: (2008) -
A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
por: Thrane, Susan, et al.
Publicado: (2015)